Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 7 of 7 for “"Non-Hodgkin’s lymphomas"”.
-
Analysis of the Role of Circulating Platelet-Neutrophil Complexes as Regulators of Tumour-Induced Netosis in Indolent and Aggressive Non-Hodgkin’s Lymphomas // Анализ на ролята на циркулиращите неутрофилно-тромбоцитни комплекси като регулатори на тумор-индуцираната нетоза при индолентни и агресивни Нехочкинови лимфоми
Нехочкиновите лимфоми (НХЛ) са хетерогенна група клонални заболявания на лимфната тъкан с разнообразен спектър от клинични, биологични и хистопатологични характеристики. Патофизиологично те са свързани със значими промени в имунната реактивност и клетъчната хомеостаза. Взаимодействието между …
-
Μελέτη ανασυνδυασμού DNA σε υπερπλασίες του λεμφικού συστήματος και λεμφώματα
… 30 cases of malignant lymphoproliferations-Hodgkin’s disease and non-Hodgkin’s lymphomas - and no clonal rearrangements were detected in Hodgkin’s disease with high numbe of Reed-Sternberg cells and in subtypes of peripheral T-cell lymphomas. The biological significance of these data relies …
-
Type I Insulin-Like Growth Factor Receptor Tyrosine Kinase As A Molecular Target In Mantle Cell Lymphoma
… lymphoid malignancy representing 5-10% of all non-Hodgkin’s lymphomas. It is distinguished by the t(11;14)(q13;q32) chromosomal translocation that juxtaposes the proto-oncogene CCND1, which encodes cyclin D1 at 11q13 to the IgH gene at 14q32. MCL patients represent about 6% of all new cases of …
-
The synergistic interaction between CD20 monoclonal antibodies and Histone Deacetylase inhibitors in B cell Non Hodgkin’s Lymphoma
Recent improvements in molecular sub typing of Non Hodgkin’s lymphomas<br/>have resulted in targeted therapies becoming incorporated into treatment<br/>paradigms. The anti-CD20 monoclonal antibody, Rituximab, has resulted in<br/>dramatic improvements in survival for patients with B cell Non …
-
The Biology of Mantle Cell Lymphoma: Exploring the Gender Difference in Mantle Cell Lymphoma
… neoplasm that accounts for approximately 4-8% of non-Hodgkin’s lymphomas (NHLs). The median age at diagnosis is 65 years with a male to female predominance of 3:1. It has also been demonstrated that female MCL patients have a greater response to therapy, especially immunomodulatory therapy …
-
Expression levels of miRNA-127 in a cohort of HIV-positive and HIV-negative Diffuse Large B-Cell Lymphoma.
… Large B Cell Lymphoma is one of the most common Non-Hodgkin’s Lymphomas. It is prevalent in older age patients but as of late there has been a rise in the younger population in South Africa due to the rise of HIV. DLBCL is quite an aggressive cancer but can be treated, however the relapse rate is …
-
HIV alters the expression of miRNA hsa-miR-200c-3p in B-cells, leading to enhanced migration of lymphoma cells
… with co-morbidities, including HIV-associated Non-Hodgkin’s Lymphomas (HIV-NHLs). Burkitt’s lymphoma (BL), a highly aggressive cancer, is one of the most common NHLs associated with HIV infection. Despite receiving highly active anti-retroviral therapy, the prognosis for this HIV-associated …